United States· US:83564-110_2ca3c2b8-a86b-4e5e-894a-6529e03052e0
Symvess
A medicinal product containing acellular tissue engineered vessel, registered in United States by Humacyte Global, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ACELLULAR TISSUE ENGINEERED VESSEL
- Manufacturer
- Humacyte Global, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1183564110001 BOX in 1 BAG (83564-110-00) / 1 IMPLANT in 1 BOX (83564-110-01)
- ndc1183564-110-00
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f93d0326-6307-423a-9d9f-256a4e91f3a2 GET /v1/drugs/f93d0326-6307-423a-9d9f-256a4e91f3a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVASCULAR",
"source": "ndc",
"strength": "420",
"substance": "ACELLULAR TISSUE ENGINEERED VESSEL",
"productndc": "83564-110",
"dosage_form": "IMPLANT",
"dea_schedule": null,
"strength_unit": "mm/1",
"application_number": "BLA125812",
"marketing_category": "BLA"
}See everything about acellular tissue engineered vessel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.